Exact Mass: 333.1325

Exact Mass Matches: 333.1325

Found 25 metabolites which its exact mass value is equals to given mass value 333.1325, within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error 0.0002 dalton.

gamma-Glutamyltryptophan

(2S)-2-amino-4-{[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}butanoic acid

C16H19N3O5 (333.1325)


gamma-Glutamyltryptophan is a dipeptide composed of gamma-glutamate and tryptophan, and is a proteolytic breakdown product of larger proteins. It belongs to the family of N-acyl-alpha amino acids and derivatives. These are compounds containing an alpha amino acid which bears an acyl group at its terminal nitrogen atom. gamma-Glutamyltryptophan is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

   

Glutamyltryptophan

(4S)-4-amino-4-{[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}butanoic acid

C16H19N3O5 (333.1325)


Glutamyltryptophan is a dipeptide composed of glutamate and tryptophan, and is a proteolytic breakdown product of larger proteins. It belongs to the family of N-acyl-alpha amino acids and derivatives. These are compounds containing an alpha amino acid which bears an acyl group at its terminal nitrogen atom. Glutamyltryptophan is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. Glutamyltryptophan can be found in feces (PMID: 27015276). The synthetic version of this dipeptide is named Oglufanide. It was originally developed to treat severe infectious disease in Russia (where it is a registered pharmaceutical), and was extensively studied in cancer clinical trials in the United States before being acquired by Implicit Bioscience in 2005. Oglufanide works as a regulator of the bodys immune response and is being given by intranasal administration to patients with chronic hepatitis C viral infection (DB05779). C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor C308 - Immunotherapeutic Agent Oglufanide (H-Glu-Trp-OH) is a dipeptide immunomodulator isolated from calf thymus. Oglufanide inhibits vascular endothelial growth factor (VEGF). Oglufanide can stimulate the immune response to hepatitic C virus (HCV) and intracellular bacterial infections. Oglufanide shows antitumor and anti-angiogenesis activities[1][2][3]. Oglufanide (H-Glu-Trp-OH) is a dipeptide immunomodulator isolated from calf thymus. Oglufanide inhibits vascular endothelial growth factor (VEGF). Oglufanide can stimulate the immune response to hepatitic C virus (HCV) and intracellular bacterial infections. Oglufanide shows antitumor and anti-angiogenesis activities[1][2][3].

   

Tryptophyl-Glutamate

2-{[2-amino-1-hydroxy-3-(1H-indol-3-yl)propylidene]amino}pentanedioate

C16H19N3O5 (333.1325)


Tryptophyl-Glutamate is a dipeptide composed of tryptophan and glutamate. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

   

10-Acetoxydecarbamoylmitomycin C

{11-amino-7-methoxy-12-methyl-10,13-dioxo-2,5-diazatetracyclo[7.4.0.0^{2,7}.0^{4,6}]trideca-1(9),11-dien-8-yl}methyl acetate

C16H19N3O5 (333.1325)


   

Golotimod

2-amino-4-{[1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}butanoic acid

C16H19N3O5 (333.1325)


   
   
   

C16H19N3O5_11-Hydroxy-11-isopropyl-4-methoxy-8-methyl-10,11-dihydro-6H-oxepino[2,3-d]pyrazino[1,2-a]pyrimidine-6,9(8H)-dione

NCGC00380446-01_C16H19N3O5_11-Hydroxy-11-isopropyl-4-methoxy-8-methyl-10,11-dihydro-6H-oxepino[2,3-d]pyrazino[1,2-a]pyrimidine-6,9(8H)-dione

C16H19N3O5 (333.1325)


   
   
   

11-Hydroxy-11-isopropyl-4-methoxy-8-methyl-10,11-dihydro-6H-oxepino[2,3-d]pyrazino[1,2-a]pyrimidine-6,9(8H)-dione

11-Hydroxy-11-isopropyl-4-methoxy-8-methyl-10,11-dihydro-6H-oxepino[2,3-d]pyrazino[1,2-a]pyrimidine-6,9(8H)-dione

C16H19N3O5 (333.1325)


   

TRP-Glu

TRP-Glu

C16H19N3O5 (333.1325)


A dipeptide formed from L-tryptophan and L-glutamic acid residues.

   

(S)-N-[{3-(4-(3-oxomorpholin-4-yl)phenyl)-2-oxo-1,3-oxazolidin-5-yl}methyl]acetamide

(S)-N-[{3-(4-(3-oxomorpholin-4-yl)phenyl)-2-oxo-1,3-oxazolidin-5-yl}methyl]acetamide

C16H19N3O5 (333.1325)


   

Golotimod

Golotimod

C16H19N3O5 (333.1325)


C308 - Immunotherapeutic Agent > C129820 - Antineoplastic Immunomodulating Agent C274 - Antineoplastic Agent Golotimod (SCV-07), an immunomodulating peptide with antimicrobial activity, significantly increases the efficacy of antituberculosis therapy, stimulates thymic and splenic cell proliferation, and improves macrophage function. Golotimod (SCV-07) inhibits STAT3 signaling and modulates the duration and severity of oral mucositis in animal models that received radiation or a combination of radiation and Cisplatin. Golotimod (SCV-07) is also a potential therapeutic for recurrent genital herpes simplex virus type 2 (HSV-2)[1][2][3].

   

Ethonam nitrate

Ethonam nitrate

C16H19N3O5 (333.1325)


C254 - Anti-Infective Agent > C514 - Antifungal Agent

   

(11-Amino-7-methoxy-12-methyl-10,13-dioxo-2,5-diazatetracyclo[7.4.0.02,7.04,6]trideca-1(9),11-dien-8-yl)methyl acetate

(11-Amino-7-methoxy-12-methyl-10,13-dioxo-2,5-diazatetracyclo[7.4.0.02,7.04,6]trideca-1(9),11-dien-8-yl)methyl acetate

C16H19N3O5 (333.1325)


   

3-O-ethylentacapone

3-O-ethylentacapone

C16H19N3O5 (333.1325)


   

Dibutyl 2-(N-trifluoroacetylamino)ethylphosphonate

Dibutyl 2-(N-trifluoroacetylamino)ethylphosphonate

C12H23F3NO4P (333.1317)


   

Butyl N-trifluoroacetyl 1-aminoethyl phosphonate

Butyl N-trifluoroacetyl 1-aminoethyl phosphonate

C12H23F3NO4P (333.1317)


   

5-Tert-butyl-2,3-dimethoxycarbonyl-5,6-dihydropyrrolo(1,2-D)(1,2,4)triazocin-6-one

5-Tert-butyl-2,3-dimethoxycarbonyl-5,6-dihydropyrrolo(1,2-D)(1,2,4)triazocin-6-one

C16H19N3O5 (333.1325)


   

Oglufanide

H-Glu-Trp-OH

C16H19N3O5 (333.1325)


C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor C308 - Immunotherapeutic Agent Oglufanide (H-Glu-Trp-OH) is a dipeptide immunomodulator isolated from calf thymus. Oglufanide inhibits vascular endothelial growth factor (VEGF). Oglufanide can stimulate the immune response to hepatitic C virus (HCV) and intracellular bacterial infections. Oglufanide shows antitumor and anti-angiogenesis activities[1][2][3]. Oglufanide (H-Glu-Trp-OH) is a dipeptide immunomodulator isolated from calf thymus. Oglufanide inhibits vascular endothelial growth factor (VEGF). Oglufanide can stimulate the immune response to hepatitic C virus (HCV) and intracellular bacterial infections. Oglufanide shows antitumor and anti-angiogenesis activities[1][2][3].

   

gamma-Glutamyltryptophan

gamma-Glutamyltryptophan

C16H19N3O5 (333.1325)


   

Glu-TRP

Glu-TRP

C16H19N3O5 (333.1325)


A dipeptide composed of L-glutamic acid and L-tryptophan joined by a peptide linkage.

   

methyl (1s,5s)-4-hydroxy-6-[4-(methoxycarbonyl)phenyl]-8-methyl-3,6,8-triazabicyclo[3.2.1]oct-3-ene-5-carboxylate

methyl (1s,5s)-4-hydroxy-6-[4-(methoxycarbonyl)phenyl]-8-methyl-3,6,8-triazabicyclo[3.2.1]oct-3-ene-5-carboxylate

C16H19N3O5 (333.1325)


   

methyl 4-hydroxy-6-[4-(methoxycarbonyl)phenyl]-8-methyl-3,6,8-triazabicyclo[3.2.1]oct-3-ene-5-carboxylate

methyl 4-hydroxy-6-[4-(methoxycarbonyl)phenyl]-8-methyl-3,6,8-triazabicyclo[3.2.1]oct-3-ene-5-carboxylate

C16H19N3O5 (333.1325)